Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life

Frontiers in Psychology

article

Stian Solem¹  Leif Edward Ottesen Kennair¹  Roger Hagen¹  Audun Havnen¹  Hans M. Nordahl²  Adrian Wells⁴  Odin Hjemdal¹ 

[1] Department of Psychology, Norwegian University of Science and Technology;Department of Mental Health, Norwegian University of Science and Technology (NTNU);Division of Psychiatry, St. Olavs Hospital;Faculty of Biology, Medicine and Health, School of Psychological Sciences, Manchester Academic Health Science Centre, The University of Manchester, United Kingdom;Greater Manchester Mental Health NHS Trust, United Kingdom

关键词: depression;    metacognitive therapy;    metacognition;    long-term follow-up;    recovery;    relapse prevention;    quality of life;   

DOI  :  10.3389/fpsyg.2019.02908

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

A major challenge in the treatment of depression has been high relapse rates following treatment. The current study reports results from a 3-year follow-up of patients treated with metacognitive therapy (MCT). Thirty-four of the 39 patients enrolled in the original study attended assessment (participation rate of 87%). There were large reductions in symptoms of depression, anxiety, interpersonal problems, and worry, as well as metacognitive beliefs. Three patients fulfilled diagnostic criteria for axis-I disorders: one with depression and two with generalized anxiety disorder. Sixty percent had not experienced any new depressive episodes in the 3-year follow-up period, and the static relapse rates were low (11–15%). Recovery rates ranged from 69 to 97% depending upon the four different criteria used. Nevertheless, 26% had sought out treatment for depression or other psychological difficulties. Most patients (70%) had experienced negative life events in the follow-up period, but these events did not influence current depression severity. Return to work outcomes were encouraging, as eight out of 13 patients that had been on benefits were no longer receiving benefits. Life satisfaction ratings showed mean scores around 70 (on a 0–100 scale) and showed a moderate to strong negative correlation with depression severity. In conclusion, MCT appears to be promising with respect to long-term effect. Randomized controlled trials should investigate if the long-term effect of MCT surpasses that of other evidence-based treatments for depression.

【 授权许可】

CC BY